Relationship between R&D and Financial Performance in Indian Pharmaceutical Industry

2022 ◽  
Author(s):  
Mithun Nandy
Keyword(s):  
Pharmaceutical Industry ◽  
Financial Performance ◽  
Indian Pharmaceutical Industry

scholarly journals Effect of Financial Performance on Profitability in Indian Pharmaceutical Companies

2019 ◽  
Vol 8 (6) ◽  
pp. 4910-4916
Keyword(s):  
Pharmaceutical Industry ◽  
Financial Performance ◽  
National Economy ◽  
Pharmaceutical Companies ◽  
Government Control ◽  
Pharmaceutical Sector ◽  
Drug Store ◽  
Indian Pharmaceutical Industry

The total Indian pharmaceutical sector is exceedingly divided with in excess of 20,000 enlisted units. It has spread drastically over the most recent two decades. The pharmaceutical and the chemical industries in India is an amazingly separated market with solid value rivalry and government control. The pharmaceutical business in India meets around 705 of the nation's interest in bulk medications, pharmaceutical formulas, synthetics, tablets, oral and injectables. There are around 250 enormous units and around 8,000 SMUs, which structure the centre of the pharmaceutical business in India, including 4 Pubilc sector units. Looking forward, the worldwide drug store market is assessed at more than to 1.5 billion dollars constantly in 2020. The Indian pharmaceutical industry is growing significantly every year. The primary goal of this research unmistakably demonstrates that pharmaceutical organizations are working great as an industry as well as can add growth to the development of the national economy. In this way, we made an attempt to find the effect of financial performance on profitability.

scholarly journals A study on working capital management of pharmaceutical industry in india

2015 ◽  
Vol 1 (3) ◽  
pp. 248-269
Author(s):  
Vijayalakshmia V ◽  
Srividya M
Keyword(s):  
Standard Deviation ◽  
Pharmaceutical Industry ◽  
Financial Performance ◽  
Chemical Industry ◽  
Price Competition ◽  
Working Capital ◽  
Working Capital Management ◽  
A Company ◽  
Indian Pharmaceutical Industry

The Indian Pharmaceutical sector is highly fragmented with more than 20,000 registered units. It has expended drastically in the last two decades. The pharmaceutical and chemical industry in India is an extremely fragmented market with severe price competition and government price control. The Pharmaceutical Industry in India meets around 705 of the country‟s demand for bulk drugs, drug intermediates, pharmaceutical formulation, chemicals,tablets, orals and injectibles. The Indian Pharmaceutical Industry is developing drastically every year. It is felt that there is the need to study the role of working capital on profitability of a Pharmaceutical company. Conventionally, it has been seen that if a company desires to take a greater risk for bigger profits and losses, it reduces the size of its working capital in relation to its sales. If it is interested in improving its liquidity, it increases the level of its working capital.Hence an attempt has been made to analyze the working capital position of the industry with the help of mean, standard deviation, co-efficient of variation, multiple regression, and analysis of variance. The increase in working capital will improve the financial performance in future.

scholarly journals Assessing Impact of Liberalization on Financial Performance Sustainability of Indian Pharmaceutical Industry using Structure Conduct Performance Model

2021 ◽  
Vol 12 (3) ◽  
pp. 3085-3091
Author(s):  
Dr. Pankaj Talreja Et.al
Keyword(s):  
Pharmaceutical Industry ◽  
Financial Performance ◽  
Market Structure ◽  
Firm Size ◽  
Performance Model ◽  
Raw Material ◽  
Direct Impact ◽  
Pharmaceutical Firms ◽  
Immense Potential ◽  
Indian Pharmaceutical Industry

The Indian Pharmaceutical Industry is ranked third largest by volume and fourteenth by value. It thus accounts for 10% of world’s production by volume and 1.5% by value according to Department of Pharmaceuticals, Government of India. Recognizing the immense potential for growth of Indian pharmaceutical industry and its direct impact on Indian economy the present paper tries to analyze the market structure of the Indian pharmaceutical firms and assess how the sustainable profitability of firms is affected using structure conduct performance model. The study founds out the sustainable profitability is statistically related to firm size, export and import, raw material expenses, power use and wage intensity but there seems to be insignificant effect of market share and mergers and acquisition on firm’s performance in terms of sustainable profitability.

scholarly journals A study on financial performance of pharmaceutical industry in india

2014 ◽  
Vol 1 (3) ◽  
pp. 191-209
Author(s):  
Vijayalakshmi V ◽  
Srividya M
Keyword(s):  
Standard Deviation ◽  
Public Sector ◽  
Pharmaceutical Industry ◽  
Financial Performance ◽  
Analysis Of Variance ◽  
Chemical Industry ◽  
Price Competition ◽  
Small Scale ◽  
The Core ◽  
Indian Pharmaceutical Industry

The Indian Pharmaceutical sector is highly fragmented with more than 20,000 registered units. It has expended drastically in the last two decades. The pharmaceutical and chemical industry in India is an extremely fragmented market with severe price competition and government price control. The Pharmaceutical Industry in India meets around 705 of the country‟s demand for bulk drugs, drug intermediates, pharmaceutical formulation, chemicals,tablets, orals and injectibles. There are approximately 250 large units and about 8000 small-scale units, which form the core of the Pharmaceutical Industry in India (including 5 central public sector units) Looking ahead, the worldwide pharma market is estimated to more than double to $1.3 billion by the year 2020.The Indian Pharmaceutical Industry is developing drastically every year. Hence an attempt has been made to analyze the profitability position of the industry withthe help of mean, standard deviation, co-efficient of variation, multiple regression, and analysis of variance. The increase in profitability will not only yield greater efficiency but also improve financial performance in future.

The Influence of TRIPS Compliant Patent Laws on Indian Pharmaceutical Industry

2014 ◽  
Vol 4 (1) ◽  
Author(s):  
Rupesh Rastogi ◽  
Virendra Kumar
Keyword(s):  
Pharmaceutical Industry ◽  
Patent Protection ◽  
Uruguay Round ◽  
Pharmaceutical Products ◽  
Trips Agreement ◽  
Patent Law ◽  
Patent Laws ◽  
The Impact ◽  
First Time ◽  
Indian Pharmaceutical Industry

The first legislation in India relating to patents was the Act VI of 1856. The Indian Patents and Design Act, 1911 (Act II of 1911) replaced all the previous Acts. The Act brought patent administration under the management of Controller of Patents for the first time. After Independence, it was felt that the Indian Patents & Designs Act, 1911 was not fulfilling its objective. Various comities were constituted to recommend, framing a patent law which can fulfill the requirement of Indian Industry and people. The Indian Patent Act of 1970 was enacted to achieve the above objectives. The major provisions of the act, provided for process, not the product patents in food, medicines, chemicals with a term of 14 years and 5-7 for chemicals and drugs. The Act enabled Indian citizens to access cheapest medicines in the world and paved a way for exponential growth of Indian Pharmaceutical Industry. TRIPS agreement, which is one of the important results of the Uruguay Round, mandated strong patent protection, especially for pharmaceutical products, thereby allowing the patenting of NCEs, compounds and processes. India is thereby required to meet the minimum standards under the TRIPS Agreement in relation to patents and the pharmaceutical industry. India’s patent legislation must now include provisions for availability of patents for both pharmaceutical products and processes inventions. The present paper examines the impact of change in Indian Patent law on Pharmaceutical Industry.

Sign in / Sign up

Export Citation Format

Share Document